SYNLIBRA

Welcome to the Brand page for “SYNLIBRA”, which is offered here for Pharmaceutical preparations for the diagnosis and treatment of movement disorders and neurological and neuropsychiatric disorders; pharmaceutical preparations for the diagnosis and treatment of tardive dyskinesia, posttraumatic stress disorder (ptsd), tourette syndrome and other movement disorders and neurological and neuropsychiatric disorders;providing medical information in the fields of movement disorders and neurological and neuropsychiatric disorders; providing medical information relating to pharmaceuticals;pharmaceutical research and development; biological research; medical research; medical and scientific research, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; scientific research for medical purposes in the fields of movement disorders and neurological and neuropsychiatric disorders; scientific research for medical purposes in the fields of tardive dyskinesia, posttraumatic stress disorder (ptsd), tourette syndrome and other movement disorders and neurological and neuropsychiatric disorders;.

Its status is currently believed to be active. Its class is unavailable. “SYNLIBRA” is believed to be currently owned by “Synchroneuron Inc.”